KHRN.V - Khiron Life Sciences Corp.

TSXV - TSXV Delayed Price. Currency in CAD
2.2200
-0.1000 (-4.31%)
As of 3:23PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close2.3200
Open2.2500
Bid2.2100 x 0
Ask2.2200 x 0
Day's Range2.2000 - 2.3000
52 Week Range0.8700 - 4.3500
Volume130,101
Avg. Volume655,560
Market Cap245.183M
Beta (3Y Monthly)3.89
PE Ratio (TTM)N/A
EPS (TTM)-0.4360
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.75
  • Market Exclusive8 hours ago

    Cannabis Stock News Daily Roundup July 18

    CannabCo Pharmaceutical Corp. Colombia S.A.S., a Colombia based cannabis cultivator and manufacturer of medical cannabis products, has completed a deal with Invest In Orinoquia for the development of thousands of hectares of cannabis and hemp production in the Los Llanos region of Colombia. The joint venture will proceed with the deployment of "purpose-built" cannabis greenhouses […]The post Cannabis Stock News Daily Roundup July 18 appeared first on Market Exclusive.

  • CNW Groupyesterday

    Khiron Obtains Final Approval to Commercialize CBD Production and Receives Approval for an additional 17 Cannabis Strains from Colombian Agricultural Institute

    Khiron has now secured all approvals required to commercialize current CBD cultivation and production for medical purposes. Khiron has now registered a total of 22 strains with Colombian Agricultural Institute ("ICA"). TORONTO , July 17, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a vertically integrated cannabis leader with core operations in Latin America , announced today that it has received approval from the National Cultivar Registry and the Technical Direction of the ICA for the commercialization of 17 stains of cannabis.

  • Market Exclusive2 days ago

    Khiron Is Only Colombian Company Generating Cannabis Revenues from Legal Production

    Khiron Life Sciences (TSXV: KHRN) (OTCQB: KHRNF) has issued an update on core commercial and operational activities. The update outlines the company's position related to commercial revenue generating activities as well as an operational update on the status of the cultivation, extraction and testing facilities. It states that, as a result of the ILANS acquisition […]The post Khiron Is Only Colombian Company Generating Cannabis Revenues from Legal Production appeared first on Market Exclusive.

  • Benzinga2 days ago

    Khiron Life Sciences To Participate At Cosmoprof North America

    Khiron Life Sciences Corp. (TSXV: KHRN), (OTCQB: KHRNF ) announced Tuesday it will take part in Cosmoprof North America, a leading B2B beauty show in North America. The event will be held at the Mandalay ...

  • CNW Group2 days ago

    Khiron Targets Over 40,000 Beauty Industry Leaders with Kuida Skin Care Brand at Cosmoprof North America

    Khiron Targets Over 40,000 Beauty Industry Leaders with Kuida Skin Care Brand at Cosmoprof North America

  • Market Exclusive3 days ago

    Cannabis Stock News Daily Roundup July 15

    Canada-based cannabis company Cannara Biotech (CSE: LOVE) (FRA: 8CB) (OTCMKTS: LOVFF) has raised $2,160,000 through non-brokered private placement of common shares at $0.18 apiece. The net proceeds from will be used for general corporate purposes including the ongoing build-out at the company’s facility and to provide additional working capital. Cannabis One Holdings (CSE: CBIS) (OTCMKTS:CAAOF) has […]The post Cannabis Stock News Daily Roundup July 15 appeared first on Market Exclusive.

  • Khiron Life Sciences Corp. (CVE:KHRN): When Will It Breakeven?
    Simply Wall St.3 days ago

    Khiron Life Sciences Corp. (CVE:KHRN): When Will It Breakeven?

    Khiron Life Sciences Corp.'s (CVE:KHRN): Khiron Life Sciences Corp. operates as an integrated cannabis company in...

  • CNW Group3 days ago

    Khiron Provides Corporate Update on Commercial and Operational Activities

    Colombia commercial production anticipated to be commercialized in Q3. Wellness line secured distribution agreements with largest retails of product category throughout Colombia , across 176 points of sale. TORONTO , July 15, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a vertically integrated cannabis leader with core operations in Latin America , is pleased to provide a corporate update on core commercial and operational activities.

  • Market Exclusive9 days ago

    Cannabis Stock News Daily Roundup July 9

    Wellness and CBD brand Kaleidoscope Labs has raised a $4 million seed round support their expansion efforts. New York-based venture capital firm RRE Ventures led the round with participation from Barry Rosenstein, founder of JANA Partners. SOL Global Investments (CSE: SOL) (OTCQB: SOLCF) (Frankfurt: 9SB) has completed a $50 million private placement financing by way of the […]The post Cannabis Stock News Daily Roundup July 9 appeared first on Market Exclusive.

  • CNW Group9 days ago

    Khiron CEO Alvaro Torres to Present at 2019 Canaccord Genuity U.S. Annual Growth Conference

    TORONTO , July 9, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (KHRNF), (Frankfurt:A2JMZC), a cannabis company with core operations in Latin America, announced today that the Company will be presenting at the 39th annual Canaccord Genuity Growth Conference, taking place in Boston, MA , August 7-8, 2019 .

  • PR Newswire10 days ago

    Khiron Leads Cannabis Education at XLIV International Course of Internal Medicine, Reaching Over 2,000 Medical Specialists in Mexico

    TORONTO, July 8, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV:KHRN, OTCQB:KHRNF), a cannabis company with core operations in Latin America announced today its participation in the XLIV International Course of Internal Medicine conference, which took place from July 3-6 in Monterrey, Mexico. Organized by the Mexican College of Internal Medicine, Khiron was the only cannabis company to participate in this year's conference, where it joined over 2000 physicians and medical specialists to inform, educate and discuss medical cannabis knowledge and developments.

  • CNW Group15 days ago

    Grit Capital's Millennial Virtual Investor Conference Now Available for On-Demand Viewing

    Grit Capital's Millennial Virtual Investor Conference Now Available for On-Demand Viewing

  • CNW Group17 days ago

    Khiron Welcomes EU Trade Deal with Latin American Countries

    TORONTO , July 1, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a cannabis company with core operations in Latin America, applauds the EU-Mercosur Trade Agreement announced between the European Union and Mercosur, the Latin American trading block made up of Argentina , Brazil , Uruguay and Paraguay . Khiron is active among Mercosur jurisdictions with a recently completed acquisition of NettaGrowth International, a cannabis company based in Uruguay .

  • CNW Group23 days ago

    Khiron President Chris Naprawa to Participate in Grit Capital Virtual Investor Conference

    TORONTO , June 25, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a cannabis company with core operations in Latin America, announces today that Company president Chris Naprawa will be presenting at the Grit Capital Virtual Investor Conference to be hosted on June 26, 2019 . Khiron has core operations in Latin America and is fully licensed in the country for the cultivation, production, domestic distribution, and international export of both THC (tetrahydrocannabinol) and CBD (cannabidiol) medical cannabis.

  • CNW Group27 days ago

    Grit Capital's Live-Stream Virtual Investor Conference June 26th

    Grit Capital's Live-Stream Virtual Investor Conference June 26th

  • CNW Group29 days ago

    Khiron Completes Acquisition of NettaGrowth International Advancing Multi-Country Operator Strategy

    TORONTO , June 19, 2019 /CNW/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), a cannabis company with core operations in Latin America, announces that it has completed the acquisition of NettaGrowth International Inc. ("NettaGrowth"), previously announced on January 25, 2019 and April 9, 2019 , and its wholly-owned subsidiary Dormul S.A. ("Dormul"), a Uruguayan company that has obtained the first licence to produce and export medical cannabis with THC for commercialization in Uruguay . As consideration for the acquisition of NettaGrowth, Khiron has issued 8,498,821 common shares to the shareholders of NettaGrowth at a deemed price of $1.61 per common share.

  • PR Newswirelast month

    Khiron Announces Changes to Leadership Team with Appointment of Wendy Kaufman as CFO

    TORONTO, June 14, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (KHRN.V), (KHRNF), (Frankfurt: A2JMZC), a cannabis company with core operations in Latin America, today announced the appointment of Wendy Kaufman as CFO, effective July 2, 2019. Ms. Kaufman, a Chartered Professional Accountant, brings over 20 years of international financial experience, having served most recently as CFO at Pasinex Resources Limited.  Ms. Kaufman has significant experience with Latin American operations, gained during her tenure as CFO at Primero Mining Corporation, and previously in her role as Vice President, Finance and Treasury at Inmet Mining Corporation, among other executive management positions.